SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-002651
Filing Date
2022-01-05
Accepted
2022-01-05 16:09:05
Documents
12
Period of Report
2022-01-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d281285d8k.htm   iXBRL 8-K 24880
  Complete submission text file 0001193125-22-002651.txt   147784

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rani-20220102.xsd EX-101.SCH 2914
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rani-20220102_lab.xml EX-101.LAB 18121
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rani-20220102_pre.xml EX-101.PRE 11419
6 EXTRACTED XBRL INSTANCE DOCUMENT d281285d8k_htm.xml XML 3370
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 22511205
SIC: 2834 Pharmaceutical Preparations